Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 791 results for "continuous renal replacement therapy"

World's First Miniaturized Dialysis Machine Saves Infants' Lives
Medical Design Online

Early mobilization on continuous renal replacement therapy is ...

Research Yi Tian Wang , Terry P Haines , Paul Ritchie , Craig Walker , Teri A Ansell , Danielle T Ryan , Phaik-Sim Lim , Sanjiv Vij , Rebecca Acs , Nigel Fealy and Elizabeth H Skinner Critical Care 2014, 18 :R161 doi:10.1186/cc14001 ... Critical Care, 1 day ago
Citrate Anticoagulation and Renal Replacement Therapy in PICU General Medicine eJournal, 2 weeks ago

4 images for continuous renal replacement therapy

IVTEAM, 3 weeks ago
Seminars in Dialysis, 4 months ago
Seminars in Dialysis, 4 months ago
Med India, 5 months ago

Beta-lactam antibiotic dosing during continuous renal replacement therapy: how can we optimize therapy?

Commentary Jan J De Waele and Mieke Carlier Critical Care 2014, 18 :158
 Critical Care1 month ago Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?  Critical Care1 month ago Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy  Critical Care1 month ago beta-lactam antibiotic concentrations during continuous renal replacement therapy  Critical Care2 months ago

The Urine Protein NGAL Predicts Renal Replacement Therapy, but Not Acute Kidney Injury or 90-Day Mortality in Critically Ill Adult Patients

BACKGROUND: Urine neutrophil gelatinase-associated lipocalin (uNGAL) is increasingly used as a biomarker for acute kidney injury (AKI). However, the clinical value of uNGAL with respect to AKI, renal replacement therapy (RRT), or 90-day mortality in ...
 Current Opinion in Allergy and Clinical Immunology1 month ago

Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses

The present invention is directed to a stable fluorocarbon emulsion having a continuous aqueous phase and discontinuous fluorocarbon phase comprising two fluorocarbons and surprisingly demonstrates that perfluorodecyl bromide is as effective in ...
 PharmCast1 month ago

Therapeutic Plasma Exchange in Sepsis and Septic Shock

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and ...
 General Medicine eJournal1 week ago
Seeking Alpha

Medgenics Looking To Exploit Orphan Drug Market With Its Novel Biopump Protein Therapy Technology

Summary Biopump offers an innovative method of producing and delivering therapeutic proteins or peptides through the use of a patient's own skin. Biopump offers potentially significant advantages over traditional intravenous protein therapy. In ...
 Seeking Alpha1 month ago

Amicus Therapeutics' Management Presents at UBS Global Healthcare Conference (Transcript)

Amicus Therapeutics, Inc. ( FOLD ) UBS Global Healthcare Conference Call May 21, 2014 12:00 PM ET Andrew Terry Rosenbaum UBS Investment Bank Good afternoon everyone. Welcome to the last session within this room for the 2014 UBS Healthcare ...
 Seeking Alpha2 months ago

Adjunctive Drug Therapy for Respiratory Disease in Newborns

ACTOBAT Study Group. (1995) Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet 345: 877882. Aranda, J., Gorman, W., Bergsteinsson, H. and Gunn, T. (1977) ...
 General Medicine eJournal2 months ago

Tengion Reports First Quarter 2014 Financial Results

"We are actively continuing patient enrollment in our ongoing Phase 1 clinical trials for the Neo-Kidney Augment in both Sweden and in the United States. We are also working with key opinion leaders to determine future development plans for the ...
 Morningstar.com2 months ago TENGION : Reports First Quarter 2014 Financial Results  4 Traders2 months ago
Market Pulse Navigator

PARADOX Findings Published in Endocrine Practice Describe High Burden of Illness in Patients with Hypoparathyroidism

NPS Pharmaceuticals, Inc. ( NASDAQ:NPSP ), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that published results from PARADOX the ...
 Franklin Credit Management Corporation5 days ago Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call  Yahoo! Finance4 days ago Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA  Individual.com4 weeks ago Rockwell Medical Receives FDA Approval for Calcitriol  Yahoo! Finance1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less